WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H556224
CAS#: 634911-80-1
Description: BOC-D-FMK is a useful chemical intermediate for drug synthesis. It was used for synthesis of MX1013 (a caspase inhibitor). (see British Journal of Pharmacology (2003), 140(2), 402-412).
Hodoodo Cat#: H556224
Name: BOC-D-FMK
CAS#: 634911-80-1
Chemical Formula: C11H18FNO5
Exact Mass: 263.12
Molecular Weight: 263.265
Elemental Analysis: C, 50.19; H, 6.89; F, 7.22; N, 5.32; O, 30.39
Synonym: BOC-D-FMK
IUPAC/Chemical Name: Pentanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-5-fluoro-4-oxo-, methyl ester
InChi Key: MXOOUCRHWJYCAL-UHFFFAOYSA-N
InChi Code: InChI=1S/C11H18FNO5/c1-11(2,3)18-10(16)13-7(8(14)6-12)5-9(15)17-4/h7H,5-6H2,1-4H3,(H,13,16)
SMILES Code: O=C(CC(C(CF)=O)NC(OC(C)(C)C)=O)OC
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 263.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
